CN104602673A - 包含高度取代的羟基烷基甲基纤维素的固体分散体 - Google Patents
包含高度取代的羟基烷基甲基纤维素的固体分散体 Download PDFInfo
- Publication number
- CN104602673A CN104602673A CN201380046174.5A CN201380046174A CN104602673A CN 104602673 A CN104602673 A CN 104602673A CN 201380046174 A CN201380046174 A CN 201380046174A CN 104602673 A CN104602673 A CN 104602673A
- Authority
- CN
- China
- Prior art keywords
- solid dispersion
- value
- active component
- water
- methyl celluloses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
(对比例)实施例 | 3 | 4 | 5 |
HPMC粘度,2%水溶液,20℃[mPa.s] | 105 | 3768 | 164000 |
灰土霉素在900mL磷酸缓冲液的溶解量(mg) | |||
720分后 | 15.14 | 13.51 | 5.29 |
1440分后 | 15.57 | 17.50 | 10.39 |
(对比例)实施例 | 1 | 2 | A |
20℃的粘度[mPa.s] | 2.66 | 4 | 3.1 |
x分钟后900mL磷酸缓冲液中溶解的灰土霉素(mg) | |||
4 | 260.5 | 471.9 | 393.9 |
10 | 261.9 | 133.7 | 284.2 |
20 | 175.4 | 96.8 | 114.7 |
360 | 59.0 | 46.0 | 54.7 |
(对比例)实施例 | 6 | B | 对照 |
20℃的粘度[mPa·s]1) | 7.7 | 4.3 | -- |
DS | 2.0 | 1.97 | -- |
MS | 0.8 | 0.27 | -- |
X分钟后达那唑溶解的百分比 | |||
720 | 13.2 | 6.2 | 4.8 |
1440 | 15.7 | 7.2 | 5.1 |
(对比例)实施例 | 6 | B | 对照 |
20℃的粘度[mPa·s] | 7.7 | 4.3 | -- |
DS | 2.0 | 1.97 | -- |
MS | 0.8 | 0.27 | -- |
(对比例)实施例 | 6 | B | 对照 |
X分钟后溶解的全部灰土霉素的百分数 | |||
720 | 22.4 | 17.7 | 12.1 |
1440 | 21.9 | 17.3 | 12.2 |
Claims (13)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261672409P | 2012-07-17 | 2012-07-17 | |
US61/672,409 | 2012-07-17 | ||
PCT/US2013/050213 WO2014014752A1 (en) | 2012-07-17 | 2013-07-12 | Solid dispersion comprising a highly substituted hydroxyalkyl methylcellulose |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104602673A true CN104602673A (zh) | 2015-05-06 |
CN104602673B CN104602673B (zh) | 2017-11-24 |
Family
ID=48857004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380046174.5A Active CN104602673B (zh) | 2012-07-17 | 2013-07-12 | 包含高度取代的羟基烷基甲基纤维素的固体分散体 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9962446B2 (zh) |
EP (1) | EP2874607B1 (zh) |
JP (1) | JP6235584B2 (zh) |
KR (1) | KR102160903B1 (zh) |
CN (1) | CN104602673B (zh) |
BR (1) | BR112014032017A2 (zh) |
PT (1) | PT2874607T (zh) |
WO (1) | WO2014014752A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106556567A (zh) * | 2016-10-01 | 2017-04-05 | 德州学院 | 一种羟丙基甲基纤维素羟丙基取代度的测试方法 |
WO2021134164A1 (en) * | 2019-12-30 | 2021-07-08 | Dow Global Technologies Llc | Aqueous composition and method of preparing the same |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105358133B (zh) * | 2013-07-17 | 2017-04-26 | 陶氏环球技术有限责任公司 | 用于施加到粘膜的包含羟烷基甲基纤维素的组合物 |
US10259921B2 (en) * | 2014-01-16 | 2019-04-16 | Dow Global Technologies Llc | Support materials for 3D printing |
CA2987627C (en) * | 2015-06-09 | 2023-09-19 | Dow Global Technologies Llc | Support materials for 3d printing |
JP6829244B2 (ja) * | 2015-07-27 | 2021-02-10 | ダウ グローバル テクノロジーズ エルエルシー | 生体適合性材料の付加製造方法及びその方法によって作製された物品 |
JP2023504289A (ja) | 2019-12-09 | 2023-02-02 | ニュートリション アンド バイオサイエンシス ユーエスエー 1,エルエルシー | 高度置換ヒドロキシプロピルメチルセルロース及び糖アルコールを含む組成物 |
EP4377513A1 (en) | 2021-07-28 | 2024-06-05 | Nutrition & Biosciences USA 1, LLC | Hpmc composition for providing a heat-sealable coating on paper and board |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1209740A (zh) * | 1996-05-20 | 1999-03-03 | 詹森药业有限公司 | 具有改进的生物利用度的抗真菌组合物 |
WO2003048147A2 (en) * | 2001-12-07 | 2003-06-12 | Janssen Pharmaceutica N.V. | PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES |
US8081255B2 (en) * | 2005-10-20 | 2011-12-20 | Sony Corporation | Image converting apparatus, image signal processing apparatus, camera system and image signal processing method |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2917104A1 (de) | 1979-04-27 | 1980-11-06 | Hoechst Ag | Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung |
US4678516A (en) * | 1984-10-09 | 1987-07-07 | The Dow Chemical Company | Sustained release dosage form based on highly plasticized cellulose ether gels |
US4614545A (en) | 1985-08-15 | 1986-09-30 | The Dow Chemical Company | Hydroxypropyl methyl cellulose thickening agents for organic liquids |
JPS6225101A (ja) | 1985-07-24 | 1987-02-03 | Shin Etsu Chem Co Ltd | 低重合度セルロ−スエ−テルの製造方法 |
US4734285A (en) * | 1985-10-28 | 1988-03-29 | The Dow Chemical Company | Sustained release compositions |
US5721221A (en) | 1991-03-08 | 1998-02-24 | Regents Of The University Of Minnesota | Lowering blood cholesterol levels using water soluble cellulose ethers |
JPH06239764A (ja) * | 1993-02-17 | 1994-08-30 | Yoshiaki Kawashima | 錠剤用基剤組成物およびその製造方法 |
EP0872233A1 (en) * | 1997-04-14 | 1998-10-21 | Janssen Pharmaceutica N.V. | Antiretroviral compositions with improved bioavailability |
PT901786E (pt) * | 1997-08-11 | 2007-08-07 | Pfizer Prod Inc | Disperções farmacêuticas sólidas com biodisponibilidade melhorada |
US6261218B1 (en) | 1998-12-01 | 2001-07-17 | The Dow Chemical Company | Process and apparatus for making low molecular weight cellulose ethers |
KR20010097244A (ko) | 2000-04-21 | 2001-11-08 | 유충식 | 위산도 비의존성 고용해도를 갖는 이트라코나졸 함유약학적 조성물 및 그 제조방법 |
DE10141680B4 (de) | 2001-08-25 | 2004-02-26 | Clariant Gmbh | Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern |
ES2289130T3 (es) * | 2001-09-04 | 2008-02-01 | Dow Global Technologies Inc. | Procedimiento para revestir particulas solidas. |
CL2004001884A1 (es) * | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
DE602005010074D1 (de) | 2004-05-28 | 2008-11-13 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen mit verbesserter leistung enthaltend ein hpmca polymer |
CA2641451C (en) * | 2006-02-09 | 2012-10-02 | Merck & Co., Inc. | Polymer formulations of cetp inhibitors |
ATE476966T1 (de) | 2006-10-17 | 2010-08-15 | Bend Res Inc | Feste dispersion mit schwer wasserlöslichem wirkstoff |
KR101498639B1 (ko) * | 2008-06-26 | 2015-03-11 | 에스에스 세야쿠 가부시키 가이샤 | 필름 코팅용 조성물 |
JP6185559B2 (ja) * | 2012-04-11 | 2017-08-23 | ダウ グローバル テクノロジーズ エルエルシー | 有機希釈剤およびセルロースエーテルを含む組成物 |
-
2013
- 2013-07-12 US US14/413,241 patent/US9962446B2/en active Active
- 2013-07-12 JP JP2015523138A patent/JP6235584B2/ja active Active
- 2013-07-12 WO PCT/US2013/050213 patent/WO2014014752A1/en active Application Filing
- 2013-07-12 CN CN201380046174.5A patent/CN104602673B/zh active Active
- 2013-07-12 BR BR112014032017A patent/BR112014032017A2/pt active Search and Examination
- 2013-07-12 EP EP13740163.4A patent/EP2874607B1/en active Active
- 2013-07-12 KR KR1020157001309A patent/KR102160903B1/ko active IP Right Grant
- 2013-07-12 PT PT137401634T patent/PT2874607T/pt unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1209740A (zh) * | 1996-05-20 | 1999-03-03 | 詹森药业有限公司 | 具有改进的生物利用度的抗真菌组合物 |
WO2003048147A2 (en) * | 2001-12-07 | 2003-06-12 | Janssen Pharmaceutica N.V. | PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES |
US8081255B2 (en) * | 2005-10-20 | 2011-12-20 | Sony Corporation | Image converting apparatus, image signal processing apparatus, camera system and image signal processing method |
Non-Patent Citations (1)
Title |
---|
GEERT VERRECK等: "Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion-part1", 《INTERNATIONAL JOURNAL OF PHARMACEUTICS》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106556567A (zh) * | 2016-10-01 | 2017-04-05 | 德州学院 | 一种羟丙基甲基纤维素羟丙基取代度的测试方法 |
WO2021134164A1 (en) * | 2019-12-30 | 2021-07-08 | Dow Global Technologies Llc | Aqueous composition and method of preparing the same |
Also Published As
Publication number | Publication date |
---|---|
US9962446B2 (en) | 2018-05-08 |
EP2874607B1 (en) | 2017-05-31 |
KR20150031299A (ko) | 2015-03-23 |
CN104602673B (zh) | 2017-11-24 |
PT2874607T (pt) | 2017-08-14 |
EP2874607A1 (en) | 2015-05-27 |
WO2014014752A1 (en) | 2014-01-23 |
JP6235584B2 (ja) | 2017-11-22 |
US20150140091A1 (en) | 2015-05-21 |
BR112014032017A2 (pt) | 2017-06-27 |
KR102160903B1 (ko) | 2020-10-05 |
JP2015522613A (ja) | 2015-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104602673A (zh) | 包含高度取代的羟基烷基甲基纤维素的固体分散体 | |
KR102110120B1 (ko) | 저점도의 신규한 에스테르화된 셀룰로스 에테르 | |
CN104364268B (zh) | 包含纤维素醚的熔融挤出的组合物 | |
CN104364329B (zh) | 包含有机稀释剂和纤维素醚的组合物 | |
CN103459430B (zh) | 生产具有高堆积密度和良好流动性的纤维素衍生物的方法 | |
JP6224711B2 (ja) | 部分架橋結合型エステル化セルロースエーテル | |
JP6420520B2 (ja) | 新規の高分子量及び高均一性のエステル化セルロースエーテル | |
MX2015002429A (es) | Eteres de celulosa esterificados novedosos de alto peso molecular y homogeneidad. | |
US11000594B2 (en) | Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity | |
CN104510707A (zh) | 一种泊沙康唑固体分散体及其制备方法 | |
CN101610757B (zh) | 延长释放赋形剂及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210609 Address after: New York State, USA Patentee after: Nutrition and biotechnology USA first LLC Address before: Delaware, USA Patentee before: DDP special electronic materials USA Co.,Ltd. Effective date of registration: 20210609 Address after: michigan Patentee after: THE DOW CHEMICAL Co. Address before: michigan Patentee before: DOW GLOBAL TECHNOLOGIES LLC Effective date of registration: 20210609 Address after: Delaware, USA Patentee after: DDP special electronic materials American Co. Address before: michigan Patentee before: THE DOW CHEMICAL Co. Effective date of registration: 20210609 Address after: Delaware, USA Patentee after: DDP special electronic materials USA Co.,Ltd. Address before: Delaware, USA Patentee before: DDP special electronic materials American Co. |